Phase 2 clinical trial of MYK-491 in DCM patients
Phase of Trial: Phase II
Latest Information Update: 28 Oct 2019
Price : $35 *
At a glance
- Drugs MYK 491 (Primary)
- Indications Dilated cardiomyopathy
- Focus Therapeutic Use
- 28 Oct 2019 According to a Myokardia media release, the company plans to initiate this trial in the first half of 2020.
- 13 Mar 2018 New trial record
- 08 Mar 2018 According to a Myokardia media release, this trial is expected to begin in the second half of 2018.